The media (Time, Daily Mail) are touting a new study published July 14 in the Proceedings of the National Academy of Sciences that is said to link cannabis use to anxiety and depression. The researchers studied the brains of 24 marijuana "abusers"—defined as those who smoke multiple times a day—and how they reacted to methylphenidate (more commonly known as Ritalin), a stimulant used to treat ADHD and narcolepsy. Using personality tests and brain imaging, the researchers found the cannabis users had "blunted" (no pun intended, we hope) behavioral, cardiovascular and brain responses to methylphenidate compared with control participants. The "abusers" also scored higher on negative emotional reactions. The researchers conclude that cannabis interferes with the brain's reaction to dopamine, the chemical responsible for feelings of reward and pleasure.

In another sign of the new progressive tilt in New York City politics, the
The United Kingdom's ban on possession, sale and importing of khat took effect at the end of June, officially making the midly stimulating leaf a restricted
At the semi-annual summit of the Caribbean Community (
Gov. Andrew Cuomo signed a bill into law July 7 that makes New York the 23rd medical marijuana state. Advocates celebrated a deal struck last month between Cuomo and the state legislature that will protect qualified patients from arrest, prosecution and discrimination, and license up to 20 distribution facilities across the state. The new law empowers the New York State Department of Health (
To mark
On June 26,
On June 27, Massachusetts' Department of Public Health 





Recent comments
2 weeks 6 days ago
6 weeks 5 days ago
10 weeks 5 days ago
11 weeks 3 days ago
21 weeks 3 days ago
25 weeks 4 days ago
26 weeks 4 days ago
26 weeks 4 days ago
47 weeks 5 days ago
51 weeks 6 days ago